Trial Profile
Phase II proof-of-concept trial of injectable pentoxifyline solution in patients with Peyronie's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Pentoxifylline (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
- Sponsors Harrow
- 25 Nov 2013 New trial record